- Home
- DGICB vs BME Comparison
DGICB vs BME Comparison
Compare DGICB & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | DGICB | BME |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | 851 | N/A |
| Industry | Property-Casualty Insurers | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 654.6M | 547.5M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | DGICB | BME |
|---|---|---|
| Price | $19.00 | $40.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.7K | ★ 48.8K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.26 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.84 | $35.03 |
| 52 Week High | $20.30 | $42.74 |
Technical Indicators
Market Signals| Indicator | DGICB | BME |
|---|---|---|
| Relative Strength Index (RSI) | 60.31 | 53.17 |
| Support Level | $15.57 | $37.71 |
| Resistance Level | $19.34 | $42.34 |
| Average True Range (ATR) | 0.72 | 0.77 |
| MACD | 0.22 | 0.24 |
| Stochastic Oscillator | 77.05 | 82.87 |
Price Performance
Historical ComparisonAbout DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.